WASHINGTON, Aug. 3 -- A coalition of 21 state Attorneys General submitted a public comment letter to the U.S. Department of Housing and Urban Development strongly opposing the proposed rescission of the agency's Affirmative Fair Housing Marketing Regulations. The states asserted that these regulations are vital in eradicating discriminatory housing practices and segregation in the nation's housing market. As chief law enforcement officials, the attorneys general stated their vested interest in   more

WASHINGTON, Aug. 3 -- The Cystic Fibrosis Foundation, Bethesda, Maryland, submitted a public comment letter to the U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services, U.S. Department of Labor Employee Benefits Security Administration and the U.S. Department of the Treasury Internal Revenue Service calling for improvements to the Transparency in Coverage Final Rule. The organization, which represents nearly 40,000 people with cystic fibrosis, offered several c  more

WASHINGTON, Aug. 4 -- A coalition of attorneys general from several states and municipalities has formally opposed the U.S. Department of Energy's (DOE) proposed rule to rescind energy conservation standards for external power supplies. This public comment letter, submitted on July 15, 2025, highlights concerns about the potential environmental impacts and consumer consequences of loosening energy regulations. The proposed rule, which aims to dismantle existing energy conservation measures, thr  more

WASHINGTON, Aug. 2 -- The U.S. Department of Agriculture issued the following news release: * * * Secretary Rollins Statement on Confirmation of Luke Lindberg as Under Secretary for Trade and Foreign Agricultural Affairs * (Washington, D.C., August 2, 2025) - U.S. Secretary of Agriculture Brooke L. Rollins applauds the Senate confirmation of Luke J. Lindberg as Under Secretary for Trade and Foreign Agricultural Affairs (TFAA), marking another milestone in the Trump Administration's efforts t  more

WASHINGTON, Aug. 3 -- The University of Maryland Center for Translational Medicine, Baltimore, submitted a public comment letter to the U.S. Department of Health and Human Services Food and Drug Administration providing input on the reauthorization of the Prescription Drug User Fee Act for fiscal years 2028-2032. The organization is dedicated to improving drug development through patient-focused, data-driven innovation. The letter highlights that chronic diseases affect a large portion of adult  more